PTCY
Showing 1 - 25 of 86
GVHD Trial in Shenzhen, Shanghai (PTCY)
Not yet recruiting
- GVHD
- PTCY
-
Shenzhen, GaungDong, China
- +1 more
Aug 17, 2023
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)
Recruiting
- Acute Leukemia
- +3 more
- VIC- 1911
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)
Recruiting
- Graft Vs Host Disease
- +5 more
- Cyclophosphamide
- ATG
-
Augsburg, Germany
- +15 more
Aug 2, 2022
Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,
Recruiting
- Acute Myeloid Leukemia in Remission
- +9 more
- Thymoglobulin
- +3 more
-
Antwerp, Belgium
- +9 more
Oct 5, 2021
Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)
Not yet recruiting
- Hematologic Diseases
- +2 more
- haplo-SCT with PTCy
- (no location specified)
Nov 8, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
Dec 8, 2021
Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease Trial in Australia, Canada (Cyclophosphamide, Anti-Thymocyte
Recruiting
- Acute Leukemia
- +2 more
- Cyclophosphamide
- Anti-Thymocyte globulin (rabbit)
-
Darlinghurst, New South Wales, Australia
- +8 more
Aug 30, 2021
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bone Marrow Hematopoeitic Cell Transplant (HCT)
- +9 more
- (no location specified)
Sep 27, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Cyclophosphamide
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- rivogenlecleucel
- +3 more
-
Nashville, Tennessee
- +1 more
Nov 11, 2020
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis
Not yet recruiting
- Bone Marrow Transplant Complications
- +4 more
- Sitagliptin
- +2 more
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022